Dr. Pat Whitworth on Importance of the Luminal Subtype in Breast Cance

Whitworth says that while it is generally perceived that the ER-positive/HER2-negative breast cancer patient population is the luminal subtype, 1 of every 5 of those patients would actually considered basal subtype. Whitworth says the reason this is important, is that the basal subtype normally has a much higher pathological complete response rate than the luminal subtype.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Тэги:

#targeted_oncology #oncology #cancer

Скачать видео